Search
Cullinan Therapeutics Inc
CGEMAdd to Watchlist
17.630USD
+0.350+2.03%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.08BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lynx1 Capital Advisors LLC
14.58%
MPM BioImpact LLC
12.44%
BVF Partners L.P.
9.36%
BlackRock Institutional Trust Company, N.A.
6.32%
Kynam Capital Management LP
5.07%
Other
52.22%
Shareholders
Shareholders
Proportion
Lynx1 Capital Advisors LLC
14.58%
MPM BioImpact LLC
12.44%
BVF Partners L.P.
9.36%
BlackRock Institutional Trust Company, N.A.
6.32%
Kynam Capital Management LP
5.07%
Other
52.22%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.32%
Investment Advisor/Hedge Fund
29.37%
Hedge Fund
24.94%
Research Firm
2.81%
Venture Capital
2.44%
Individual Investor
1.31%
Private Equity
0.47%
Bank and Trust
0.26%
Pension Fund
0.07%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
337
64.85M
106.02%
-14.59M
2025Q4
319
64.92M
132.11%
+3.21M
2025Q3
325
61.69M
130.11%
-1.87M
2025Q2
320
66.57M
137.49%
-2.02M
2025Q1
325
68.79M
136.24%
-10.93M
2024Q4
313
69.80M
129.09%
+695.39K
2024Q3
302
68.91M
123.19%
+1.86M
2024Q2
290
67.03M
84.28%
+21.63M
2024Q1
267
43.43M
114.51%
-5.88M
2023Q4
259
40.67M
106.23%
+2.27M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Lynx1 Capital Advisors LLC
8.96M
14.81%
--
--
Dec 31, 2025
MPM BioImpact LLC
7.65M
12.64%
--
--
Dec 31, 2025
BVF Partners L.P.
5.75M
9.5%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.89M
6.42%
+203.38K
+5.52%
Dec 31, 2025
Kynam Capital Management LP
3.11M
5.15%
+811.96K
+35.27%
Dec 31, 2025
Blue Owl Capital Holdings LP
2.35M
3.88%
-160.00K
-6.37%
Dec 31, 2025
State Street Investment Management (US)
2.20M
3.63%
+520.02K
+31.00%
Dec 31, 2025
Affinity Asset Advisors LLC
1.93M
3.19%
+1.67M
+632.37%
Dec 31, 2025
RTW Investments L.P.
1.71M
2.82%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
0.66%
Tema Oncology ETF
0.47%
State Street SPDR S&P Biotech ETF
0.09%
ProShares Ultra Nasdaq Biotechnology
0.08%
iShares Micro-Cap ETF
0.08%
Avantis US Small Cap Equity ETF
0.06%
Invesco Nasdaq Biotechnology ETF
0.05%
Direxion Daily S&P Biotech Bull 3X Shares
0.05%
iShares Russell 2000 Value ETF
0.04%
iShares Biotechnology ETF
0.03%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.66%
Tema Oncology ETF
Proportion0.47%
State Street SPDR S&P Biotech ETF
Proportion0.09%
ProShares Ultra Nasdaq Biotechnology
Proportion0.08%
iShares Micro-Cap ETF
Proportion0.08%
Avantis US Small Cap Equity ETF
Proportion0.06%
Invesco Nasdaq Biotechnology ETF
Proportion0.05%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0.05%
iShares Russell 2000 Value ETF
Proportion0.04%
iShares Biotechnology ETF
Proportion0.03%